Clinical and pharmacological group: & nbsp

Cholagogue and bile preparations

Included in the formulation
  • Tanaceol®
    pills inwards 
  • АТХ:

    A.05.A.X   Other drugs for the treatment of bile duct diseases

    Pharmacodynamics:Means of plant origin, stimulating the formation and secretion of bile, improving its biochemical composition. Has spasmolytic effect on the gallbladder, bile duct and intestine.
    Pharmacokinetics:No data.
    Indications:Noncalculous cholecystitis, biliary tract dyskinesia (hypermotor type), postcholecystectomy syndrome.

    XI.K80-K87.K81.1   Chronic cholecystitis

    XI.K80-K87.K82.8   Other specified diseases of the gallbladder

    XI.K90-K93.K91.5   Postcholecystectomy syndrome

    Contraindications:Stomach ulcer and duodenal ulcer, erosive gastroduodenitis, individual intolerance.
    Carefully:No data.
    Pregnancy and lactation:The drug is not recommended for use during pregnancy and breastfeeding without consulting a doctor.
    Dosing and Administration:Inside, after eating, 2 tablets 3 times a day. If necessary, the number of receptions is increased up to 4 times a day. The course of treatment is 20-30 days.
    Side effects:Allergic reactions, heartburn, diarrhea.
    Overdose:Cases are not registered. Treatment is symptomatic.
    Interaction:No data.
    Special instructions:According to clinical studies, the drug effectively reduces symptoms associated with impaired motor function of the intestine and biliary tract, in patients with irritable bowel syndrome, which occurs with a predominance of constipation, in combination with dysfunction of the gallbladder and ducts.
    Instructions
    Up